Delirium and multiple electrolyte abnormalities associated with high dose paroxetine exposure.
Chuang
Yi-Fang
YF
Chiu
Yen-Ling
YL
Hwang
Tzung-Jeng
TJ
Chu
Tzong-Shinn
TS
D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D003693:Delirium / Q000139:chemically induced* / Q000523:psychology; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced / Q000523:psychology; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000523:psychology; D017374:Paroxetine / Q000008:administration & dosage / Q000009:adverse effects*; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced*
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine